Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

Publication | Closed Access

DOI

237

Citations

References

2003

Year

John H. Sampson, Gamal Akabani, Gary E. Archer, Darell D. Bigner, Mitchel S. Berger, Allan H. Friedman, Henry S. Friedman, James E. Herndon, Sandeep Kunwar, Steve Marcus,

Journal of Neuro-Oncology